BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15331501)

  • 1. Simultaneous genotyping of nine polymorphisms in xenobiotic-metabolizing enzymes by multiplex PCR amplification and single base extension.
    Knaapen AM; Ketelslegers HB; Gottschalk RW; Janssen RG; Paulussen AD; Smeets HJ; Godschalk RW; Van Schooten FJ; Kleinjans JC; Van Delft JH
    Clin Chem; 2004 Sep; 50(9):1664-8. PubMed ID: 15331501
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular-epidemiological aspects of carcinogenesis: the role of xenobiotic metabolizing enzymes.
    Cascorbi I; Brockmöller J; Roots I
    Int J Clin Pharmacol Ther; 2002 Dec; 40(12):562-3. PubMed ID: 12503814
    [No Abstract]   [Full Text] [Related]  

  • 3. Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility.
    Daly AK; Cholerton S; Armstrong M; Idle JR
    Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):55-61. PubMed ID: 7698086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of the xenobiotic-metabolizing enzymes CYP1A1 and NAT-2 in systemic sclerosis and lupus erythematosus.
    von Schmiedeberg S; Fritsche E; Rönnau AC; Specker C; Golka K; Richter-Hintz D; Schuppe HC; Lehmann P; Ruzicka T; Esser C; Abel J; Gleichmann E
    Adv Exp Med Biol; 1999; 455():147-52. PubMed ID: 10599336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Polymorphism of xenobiotic detoxication genes in patients with iron deficiency anemia].
    Safuanova GSh
    Klin Lab Diagn; 2003 Jul; (7):40-2. PubMed ID: 12934333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of xenobiotic biotransformation enzymes in susceptibility to bronchial asthma and in formation of its clinical phenotypic features].
    Liakhovich VV; Vavilin VA; Makarova SI; Gavalov SM; Riabova OA; Chasovnikova OB; Gutkina NI
    Vestn Ross Akad Med Nauk; 2000; (12):36-41. PubMed ID: 11202642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
    Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
    Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity.
    Wormhoudt LW; Commandeur JN; Vermeulen NP
    Crit Rev Toxicol; 1999 Jan; 29(1):59-124. PubMed ID: 10066160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of selected xenobiotic genes contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population.
    Siraj AK; Ibrahim M; Al-Rasheed M; Abubaker J; Bu R; Siddiqui SU; Al-Dayel F; Al-Sanea O; Al-Nuaim A; Uddin S; Al-Kuraya K
    BMC Med Genet; 2008 Jul; 9():61. PubMed ID: 18601742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
    Ozawa S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No association between genetic polymorphisms of CYP1A1, GSTM1, GSTT1, GSTP1, NAT2, and nasopharyngeal carcinoma in Taiwan.
    Cheng YJ; Chien YC; Hildesheim A; Hsu MM; Chen IH; Chuang J; Chang J; Ma YD; Luo CT; Hsu WL; Hsu HH; Huang H; Chang JF; Chen CJ; Yang CS
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):179-80. PubMed ID: 12582034
    [No Abstract]   [Full Text] [Related]  

  • 12. [Genetic and phenotypic polymorphisms in carcinogen-metabolizing enzymes and cancer susceptibility].
    Watanabe M
    Nihon Rinsho; 1996 Aug; 54(8):2261-75. PubMed ID: 8810806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphic enzymes of xenobiotic metabolism as modulators of acquired P53 mutations in bladder cancer.
    Brockmöller J; Kaiser R; Kerb R; Cascorbi I; Jaeger V; Roots I
    Pharmacogenetics; 1996 Dec; 6(6):535-45. PubMed ID: 9014203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of cytochrome P450, glutathione S-transferase and N-acetyl transferase 2 gene polymorphisms with incidence of acute myeloid leukemia.
    Majumdar S; Mondal BC; Ghosh M; Dey S; Mukhopadhyay A; Chandra S; Dasgupta UB
    Eur J Cancer Prev; 2008 Apr; 17(2):125-32. PubMed ID: 18287869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of polymorphisms in xenobiotic-metabolizing genes and DNA-repair genes on diepoxybutane-induced SCE frequency.
    Laczmanska I; Gil J; Karpinski P; Stembalska A; Kozlowska J; Busza H; Trusewicz A; Pesz K; Ramsey D; Schlade-Bartusiak K; Blin N; Sasiadek MM
    Environ Mol Mutagen; 2006 Dec; 47(9):666-73. PubMed ID: 17078101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotyping metabolic polymorphisms in a cohort of Caucasians and single strand conformation polymorphism analysis of point mutations in human hprt exons 7 and 8.
    Krause G; Garganta F; Kosytorz P; Scherer G
    Electrophoresis; 1998 Oct; 19(14):2380-8. PubMed ID: 9820953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to head-and-neck squamous-cell carcinoma.
    Morita S; Yano M; Tsujinaka T; Akiyama Y; Taniguchi M; Kaneko K; Miki H; Fujii T; Yoshino K; Kusuoka H; Monden M
    Int J Cancer; 1999 Mar; 80(5):685-8. PubMed ID: 10048967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer.
    Hirvonen A
    Environ Health Perspect; 1999 Feb; 107 Suppl 1(Suppl 1):37-47. PubMed ID: 10229705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms in glutathione S-transferase mu and theta, N-acetyltransferase, and CYP1A1 and risk of gliomas.
    Trizna Z; de Andrade M; Kyritsis AP; Briggs K; Levin VA; Bruner JM; Wei Q; Bondy ML
    Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):553-5. PubMed ID: 9641501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genes and enzymes of the xenobiotic-metabolizing system in cancer pathology].
    Liakhovich VV; Vavilin VA; Gutkina NI; Laktionova IP; Makarova SI; Mitrofanov DV; Ostashevskiĭ VA; Chasovnikova OB
    Vopr Med Khim; 1997; 43(5):330-8. PubMed ID: 9446323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.